Salim S Virani1, Julia M Akeroyd2, David J Ramsey2, Winston J Chan2, Lorraine Frazier3, Khurram Nasir4, Suja S Rajan5, Christie M Ballantyne6, Laura A Petersen2. 1. Health Policy, Quality & Informatics Program, Michael E. DeBakey Veterans Affairs Medical Center Health Services Research and Development Center for Innovations; and Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, TX; Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX; Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX. Electronic address: virani@bcm.edu. 2. Health Policy, Quality & Informatics Program, Michael E. DeBakey Veterans Affairs Medical Center Health Services Research and Development Center for Innovations; and Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, TX. 3. The University of Texas Health Science Center at Houston (UTHealth) School of Nursing, Houston, TX. 4. Center for Healthcare Advancement & Outcomes at Baptist Health South Florida, Miami, FL; The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD. 5. Division of Management, Policy and Community Heath, School of Public Health, University of Texas - Health Science Center at Houston, Houston, TX. 6. Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX.
Abstract
BACKGROUND: The objective was to compare quality of diabetes and cardiovascular disease (CVD) care between advanced practice providers (APPs) and physicians in a primary care setting. METHODS: We identified diabetes (n=1,022,588) and CVD (n=1,187,035) patients receiving primary care between October 2013 and September 2014 in 130 Veterans Affairs facilities. We compared glycemic control (hemoglobin A1c <7%) in diabetic patients, blood pressure (BP) <140/90 mmHg in diabetic or CVD patients, cholesterol control (low-density lipoprotein cholesterol<100 mg/dL, receiving a statin) in diabetic or CVD patients, and those receiving a β-blocker (with history of myocardial infarction in the last 2 years) among patients receiving care from physicians and APPs. We also compared the proportion meeting composite measure (glycemic, BP, and cholesterol control in diabetic patients; BP, cholesterol control, and receipt of β-blocker among eligible CVD patients). RESULTS: Diabetic patients receiving care from APPs were statistically more likely to have glycemic (50% vs 51.4%, odds ratio [OR] 1.06 [1.05-1.08]) and BP control (77.5% vs 78.4%, OR 1.04 [1.03-1.06]), whereas patients receiving care from physicians were more likely to have cholesterol control (receipt of statin 68% vs 66.5%, OR 0.94 [0.93-0.95]) in adjusted models, although these differences are not clinically significant. Similar results were seen in CVD patients. Few patients met the composite measure (27.1% and 27.6% of diabetic and 54.0% and 54.8% of CVD patients receiving care from physicians and APPs, respectively). CONCLUSIONS: Diabetes and CVD care quality was comparable between physicians and APPs with clinically insignificant differences. Regardless of provider type, there is a need to improve performance on eligible measures in diabetes or CVD patients. Published by Elsevier Inc.
BACKGROUND: The objective was to compare quality of diabetes and cardiovascular disease (CVD) care between advanced practice providers (APPs) and physicians in a primary care setting. METHODS: We identified diabetes (n=1,022,588) and CVD (n=1,187,035) patients receiving primary care between October 2013 and September 2014 in 130 Veterans Affairs facilities. We compared glycemic control (hemoglobin A1c <7%) in diabeticpatients, blood pressure (BP) <140/90 mmHg in diabetic or CVD patients, cholesterol control (low-density lipoprotein cholesterol<100 mg/dL, receiving a statin) in diabetic or CVD patients, and those receiving a β-blocker (with history of myocardial infarction in the last 2 years) among patients receiving care from physicians and APPs. We also compared the proportion meeting composite measure (glycemic, BP, and cholesterol control in diabeticpatients; BP, cholesterol control, and receipt of β-blocker among eligible CVD patients). RESULTS:Diabeticpatients receiving care from APPs were statistically more likely to have glycemic (50% vs 51.4%, odds ratio [OR] 1.06 [1.05-1.08]) and BP control (77.5% vs 78.4%, OR 1.04 [1.03-1.06]), whereas patients receiving care from physicians were more likely to have cholesterol control (receipt of statin 68% vs 66.5%, OR 0.94 [0.93-0.95]) in adjusted models, although these differences are not clinically significant. Similar results were seen in CVD patients. Few patients met the composite measure (27.1% and 27.6% of diabetic and 54.0% and 54.8% of CVD patients receiving care from physicians and APPs, respectively). CONCLUSIONS:Diabetes and CVD care quality was comparable between physicians and APPs with clinically insignificant differences. Regardless of provider type, there is a need to improve performance on eligible measures in diabetes or CVD patients. Published by Elsevier Inc.
Authors: Emilio Fentanes; Anthony G Vande Hei; R Scott Holuby; Norma Suarez; Yousif Slim; Jennifer N Slim; Ahmad M Slim; Dustin Thomas Journal: Clin Cardiol Date: 2018-06-05 Impact factor: 2.882
Authors: Matthew E Bernard; Susan B Laabs; Darshan Nagaraju; Summer V Allen; Michael P Halasy; David R Rushlow; Gregory M Garrison; Julie A Maxson; Marc R Matthews; Gerald J Sobolik; Michelle A Lampman; Randy M Foss; Steven L Rosas; Tom D Thacher Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2021-04-08
Authors: Amit Khera; Seth J Baum; Ty J Gluckman; Martha Gulati; Seth S Martin; Erin D Michos; Ann Marie Navar; Pam R Taub; Peter P Toth; Salim S Virani; Nathan D Wong; Michael D Shapiro Journal: Am J Prev Cardiol Date: 2020-05-01
Authors: Dhruv Mahtta; David J Ramsey; Mahmoud Al Rifai; Khurram Nasir; Zainab Samad; David Aguilar; Hani Jneid; Christie M Ballantyne; Laura A Petersen; Salim S Virani Journal: JAMA Netw Open Date: 2020-08-03
Authors: Elliot J Bruhl; Kathy L MacLaughlin; Summer V Allen; Jennifer L Horn; Kurt B Angstman; Gregory M Garrison; Julie A Maxson; Debra K McCauley; Michelle A Lampman; Tom D Thacher Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2020-04-06